Treefrog Therapeutics Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 144

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 20

Treefrog Therapeutics General Information

Description

Developer of a proprietary technology platform designed to provide alternative access to cell therapies. The company's tool provides an end-to-end, three-dimensional scalable service that will reduce treatment costs as well as help cell therapy players secure cell production and quality, accelerate clinical development, and facilitate market access, enabling patients to access safe and affordable stem cell therapy.

Contact Information

Website
www.treefrog.fr
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 30 Avenue Gustave Eiffel Bâtiment A
  • 33600 Pessac
  • France
+33 07
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • 30 Avenue Gustave Eiffel Bâtiment A
  • 33600 Pessac
  • France
+33 07

Treefrog Therapeutics Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Treefrog Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
13. Accelerator/Incubator 01-Jan-2025 Completed Generating Revenue
12. Debt - General 27-Nov-2024 Completed Generating Revenue
11. Later Stage VC 03-Jan-2023 Completed Generating Revenue
10. Early Stage VC (Series B) 13-Sep-2021 Completed Generating Revenue
9. Accelerator/Incubator 01-Jan-2020 Completed Generating Revenue
8. Grant 09-Sep-2019 Completed Generating Revenue
7. Early Stage VC (Series A) 13-May-2019 Completed Generating Revenue
6. Grant 01-Mar-2019 Completed Generating Revenue
5. Seed Round 09-Jan-2019 $673K $673K Completed Generating Revenue
4. Accelerator/Incubator 01-Jan-2019 Completed Generating Revenue
To view Treefrog Therapeutics’s complete valuation and funding history, request access »

Treefrog Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary
Series A
Ordinary 11,800 $1.121089 $56.05 $56.05 1x $56.05 10.55%
To view Treefrog Therapeutics’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Treefrog Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a proprietary technology platform designed to provide alternative access to cell therapies. The company's t
Drug Discovery
Pessac, France
144 As of 2026

San Diego, CA
 

Madison, WI
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Treefrog Therapeutics Competitors (45)

One of Treefrog Therapeutics’s 45 competitors is iXCells Biotechnologies, a Private Equity-Backed company based in San Diego, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
iXCells Biotechnologies Private Equity-Backed San Diego, CA
Regenerative Medical Solutions Venture Capital-Backed Madison, WI
Sernova Biotherapeutics Corporation Mississauga, Canada
Lisata Therapeutics Corporation Basking Ridge, NJ
GenSight Biologics Formerly VC-backed Paris, France
You’re viewing 5 of 45 competitors. Get the full list »

Treefrog Therapeutics Patents

Treefrog Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20260209690-A1 Method for treating crosslinked microcompartments comprising biological elements Pending 22-Jan-2025
WO-2026159210-A1 Method for treating crosslinked microcompartments comprising biological elements Pending 22-Jan-2025
FR-3171449-A1 Process for treating cross-linked microcompartments comprising biological elements Pending 22-Jan-2025
WO-2026139294-A1 Cell encapsulation system comprising solution dispensers Pending 23-Dec-2024
FR-3170504-A1 Cell encapsulation system incorporating solution dispensers Pending 23-Dec-2024 C12M25/16
To view Treefrog Therapeutics’s complete patent history, request access »

Treefrog Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Treefrog Therapeutics Investors (20)

Investor Name Investor Type Holding Investor Since Participating Rounds
LabCentral Accelerator/Incubator
AustralianSuper Limited Partner Minority
BNP Paribas Développement PE/Buyout Minority
Nouvelle Aquitaine Co-Investissement Venture Capital Minority
Resonance VC Venture Capital Minority
You’re viewing 5 of 20 investors. Get the full list »

Treefrog Therapeutics FAQs

  • When was Treefrog Therapeutics founded?

    Treefrog Therapeutics was founded in 2018.

  • Where is Treefrog Therapeutics headquartered?

    Treefrog Therapeutics is headquartered in Pessac, France.

  • What is the size of Treefrog Therapeutics?

    Treefrog Therapeutics has 144 total employees.

  • What industry is Treefrog Therapeutics in?

    Treefrog Therapeutics’s primary industry is Drug Discovery.

  • Is Treefrog Therapeutics a private or public company?

    Treefrog Therapeutics is a Private company.

  • What is Treefrog Therapeutics’s current revenue?

    The current revenue for Treefrog Therapeutics is .

  • How much funding has Treefrog Therapeutics raised over time?

    Treefrog Therapeutics has raised $116M.

  • Who are Treefrog Therapeutics’s investors?

    LabCentral, AustralianSuper, BNP Paribas Développement, Nouvelle Aquitaine Co-Investissement, and Resonance VC are 5 of 20 investors who have invested in Treefrog Therapeutics.

  • Who are Treefrog Therapeutics’s competitors?

    iXCells Biotechnologies, Regenerative Medical Solutions, Sernova Biotherapeutics, Lisata Therapeutics, and GenSight Biologics are some of the 45 competitors of Treefrog Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process